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Renal effects and mesangial cell contraction induced by endothelin are
mediated by PAF. The recently discovered vasoactive peptide endothe-
un and platelet activating factor (PAF) share similar renal effects. The
purpose of the present series of experiments has been to analyze the
functional relations between the effect of endothelin on renal function
and glomerular and mesangial cell contraction and the production and
actions of PAF in kidney. Endothelin I nmol/kg body wt induced a
transient decrease of glomerular filtration rate (from 1.99 0. 17 to 0.56
0.18 mI/mm) and renal blood flow (from 10.8 1.3 to 2.7 0.3
mi/mm). Endothelin also induced a marked reduction of planar cell
surface area of cultured mesangial cells (30 5%) and of cross sectional
area of isolated glomeruli (from 1.51 0.02 to 1.31 0.02 m2 x l08).
BN-52021 or WEB-2 170, two potent specific inhibitors of PAF receptor
binding, blocked the effects of endothelin on renal function and on the
contraction of isolated glomeruli and mesangial cells. In addition,
endothelin induced a significant increase in the production of PAF by
isolated glomeruli (Basal, 81 10 pg/mg protein; endothelin, l0 M,
140 18 pg/mg protein). Endothelin also stimulated the incorporation
of [3H]acetate into PAF, both in glomeruli (264.27 27.7%) and
mesangial cells (251 4 1%). These effects were blocked by EGTA and
by verapamil. Our results suggest that PAF may be a mediator of the
effects of endothelin on renal function and glomerular and mesangial
cell contraction.
The potent vasoconstrictor peptide, endothelin, has been
isolated and purified from the supernatant of cultured porcine
aortic endothelial cells [11. On the other hand, platelet activat-
ing factor (PAF) is a phospholipid with a wide range of
biological activities [2, 31. Both endothelin and PAF share some
physiological properties: a) both decrease glomerular filtration
rate (GFR) and renal blood flow (RBF) when infused into the
kidney [4—71. b) Both increase packed cell volume when in-
jected intravenously, by increasing vascular permeability [2, 4,
8]. c) Both are released during ischemia [1, 91. d) Both induce
glomerular and mesangial cell contraction [10—121. e) Both
increase intracellular calcium in mesangial cells [13, 14].
The purpose of the present study was to analyze whether a
functional relationship exists between the effects of endothelin
on renal function and glomerular and mesangial cell contraction
and the production of PAF by the kidney.
Received for publication December 27, 1989
and in revised form October 22, 1990
Accepted for publication October 23, 1990
© 1991 by the International Society of Nephrology
Methods
Materials
Collagenase type I A, from Chiostridium histolyticum, EGTA
(ethyleneglycol-bis-(13-amino-ethyl-ether)N,N'-tetraacetic acid,
L-glutamine, and angiotensin II were purchased from Sigma
Chemical Co. (St. Louis, Missouri, USA). Verapamil was
provided by Knoll Spain. Penicillin was obtained from Labora-
torios Level SA, (Barcelona, Spain). A-23187 was purchased
from Sigma Chemical Co. Streptomycin sulfate was obtained
from Antibioticos SA (Madrid, Spain). RPMI 1640, Hanks
balanced salt solution and fetal calf serum were obtained from
Flow Laboratories, (Woodcock Hill, UK). Endothelin (porcine)
was purchased from Peptide Institute (Osaka, Japan). PAF was
purchased from Bachem Fine Chemicals (Bubbendorf, Switzer-
land). [H]Acetate and [1H]Serotonin were obtained from New
England Nuclear (Boston, Massachusetts, USA). BN-5202l
was a gift from Dr. P. Braquet, Institut Henry Beaufour, (Le
Plessis-Robinson, France). WEB-2 170 was purchased from
Boehringer Ingelheim KG (Germany). All the other reagents
were of the highest commercially available grade.
Renal function studies
The effect of endothelin on renal function has been studied in
16 male wistar rats weighing about 300 g. Rats were surgically
prepared for clearance studies as previously reported [15]. In
brief, under sodium phenobarbital anesthesia, PE-50 catheters
were placed in the femoral artery and vein and in the bladder.
[14C]inulin and [3HJPAH were continuously infused i.v. in order
to determine the glomerular filtration rate (GFR) and renal
plasma flow (RPF). Mean arterial pressure (MAP) was contin-
uously monitored. After a period for equilibration and hemo-
dynamic stabilization, two 20-minute basal clearance periods
were performed. Then, in one half of the animals, endothelin 1
nmol• kg body weight was infused i.v. as a bolus, and three
consecutive 20-minute clearance periods were carried out, with
blood sampling at the beginning and end of each period. The
other half of the animals were treated with a continuous
infusion with BN-5202l (5 mglhr/kg body wt) from the begin-
ning of the experiment, the remaining protocol being similar to
the other group. The effect of the infusion of BN-52021 alone
was studied in a separate group of nine animals. Sample
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handling and calculations for GFR and RPF measurement have
been previously reported [151.
Glomerular isolation and mesangial cell culture
Renal glomeruli were isolated from Wistar rats weighing 200
to 250 g and maintained on water and standard rat chow ad
libitum. Kidneys were perfused and removed under ether
anesthesia and glomeruli isolated by successive mechanical
sieving (105 and 75 tm) as previously described [16]. The final
preparation consisted of glomeruli without Bowman's capsule
and afferent or efferent arterioles; tubular contamination was
less than 5%. At least three rats were used in each set of
experiments.
For mesangial cell culture, isolated glomeruli obtained by a
mechanical sieving procedure (150 and 50 m) from rats weigh-
ing 150 to 200 g were treated with collagenase, plated in plastic
culture flasks and incubated in an air atmosphere as previously
described [17, 18]. The culture medium consisted of RPM! 1640
supplemented with 10% fetal calf serum, L-glutamine (1 mM),
penicillin (0.66 pg/ml), streptomycin sulfate (60 sgIml), and
buffered with Hepes, pH 7.2. Culture media was changed every
two days. Epithelial cells grew rapidly whereas mesangial cells
grew slowly, with a peak of mesangial cell density at 18 to 22
days. Studies were performed on day 21 or 22, at which time
epithelial cells were no longer detected in the culture flasks. The
identity of the cells was confirmed by morphological and
functional criteria: a) under phase contrast microscopy all the
cells appeared large and stellate and no cells with epithelial or
endothelial morphological characteristics were seen in the
cultures; b) by transmission electron microscopy all the cells
examined contained numerous bundles of microfilaments,
dense patches and elongated nuclei; c) mesangial cells exam-
ined were histochemically positive for actomyosin with a fib-
rilar appearance, and they did not stain for factor VIII, unlike
endothelial cells; d) the cultures did not show activity of
angiotensin converting enzyme. All the cells examined con-
tracted after incubating with PAF, angiotensin II and vasopres-
sin.
Incubation procedure
Cells or glomeruli were washed from the culture or isolation
media and placed in fresh media containing 2.5 mi CaCl2 for 30
minutes. Then agonist or antagonist were added to the incuba-
tion media as described for each specific experiment.
Determination of glomerular cross-sectional area
Samples of 100 d of glomerular suspension containing about
200 glomeruli were incubated with vehicle (Tris 20 mi, NaCI
130 m, KC1 10 mM, CaC12 2.5 m, sodium acetate 10 m and
glucose 5 mM, pH 7.45) in temperature-equilibrated (22°C)
excavated glass slides, and observed under phase contrast with
an inverted photomicroscope Olympus IMT 2 (Shibuya-Hu,
Tokyo, Japan) at 150 magnification. Serial photographs were
taken immediately before and after adding experimental agents.
Apparent glomerular cross-sectional area was determined on
the microphotographs by using a computer-aided planimetric
technique (Cardio-80, Kontron Medical, Munich, Germany).
The actual glomerular cross-sectional area (GCSA) was ob-
tained using correction factors for the microscope and micro-
photographs magnification. Measurements were performed by
two different investigators in a blind fashion.
Determination of planar surface area of mesangial cells
Direct observation of mesangial cells grown in conventional
plastic culture flasks was carried out at room temperature under
phase contrast with an inverted Olympus photomicroscope.
Serial photographs of the cells were taken before and after
experimental additions. Five to ten cells were analyzed per
photograph. In every experimental block all the cells were from
a single culture. Experiments were done by triplicate. Surface
area was determined by the computerized planimetric tech-
niques described in the paragraph above. Actual area was
calculated after correction for microscope and photographic
magnification.
Glomerular PAF production
Freshly isolated glomeruli were placed in tubes containing 1.5
ml of Tris-glucose buffer (Tris 20 mrsi, NaCl 130 mM, KC1 10
mM, CaCl 2.5 m, sodium acetate 10 m, bovine serum
albumin 0.25 mM, and glucose 5 m, pH 7.45), containing
phenylmethyl-sulfonyl fluoride (PMSF, l0- M, final concentra-
tion) to prevent rapid degradation of PAF [19]. Tubes were
incubated at 37°C for 2 or 30 minutes with either endothelin
1O M, angiotensin II iO M or isotonic saline, and glomeruli
were separated by centrifugation at 3000 rpm for three minutes.
Supernatant was mixed with 5 ml of cold methanol acidified
with acetic acid (49: 1, vol:vol), and PAF was extracted as
described below. Glomeruli were mixed with 5 ml of cold
acidified methanol, sonicated for 30 seconds, and slowly stirred
for 30 minutes. Then tubes were centrifuged and the pellet was
again mixed with 5 ml of cold methanol, stirred for 30 minutes
and centrifuged. Both methanol phases were pooled.
PAF extraction and bioassay
PAF was extracted from the methanolic phase as previously
described [20]. in brief, chloroform and water were added to the
methanol to a proportion of methanol : chloroform: water
1: 1:0.9 vol:vol, respectively, and gently stirred. After phase
formation by centrifugation, the chloroform phase was removed
and new chloroform added to the methanol: water in the same
proportion. The process was repeated and both chloroform
extracts were pooled and dried under N2 atmosphere. PAF
extraction was performed with silica cartridges (Sep-Pak, Wa-
ters, Milford, Massachusetts, USA). Cartridges were rinsed
with 5 ml of chloroform, and the sample was resuspended in 5
ml of chloroform acidified with HC1 to pH 3 to 4 and applied to
the cartridge. The column was eluted sequentially with 5 ml of
chloroform: methanol (3: 1), 5 ml of chloroform: methanol (3:2),
5 ml of chloroform: methanol (1:3), and 5 ml of methanol: water
(3: 1). The last fraction containing PAF was collected and dried
under N2 atmosphere. In preliminary studies it was observed
that POE2 and TXB2 were completely eluted from the cartridge
with the two first solvents, and that nothing of these compounds
appeared in the fractions where PAF was recovered [9]. PAF
recovery was assessed using [3H]PAF and was found to vary
between 70 and 80%.
Bioassayable PAF activity was determined by the release of
[3Hj-serotonin from preloaded rabbit platelets in the presence
of indomethacin lO_6 M, as previously described [9, 21]. A
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Table 1. Effect of endothelin (1 nmol kg') and BN-52021 (0.5 mg hr') on renal function in rats
Basal
Endothelin
0—20 20—40 40—60
MAP mm Hg —BN
+BN
128 4
123 5
129 5
120 6
130 5
121 6
125 5
121 6
UV pJ/min —BN
+BN
7.2 0.6
7.3 0.9
4.1 1.4
4.1 0.6a
6.7 1.4
6.4 0.4
8.8 0.5
8.7 1.2
GFR mi/mm —BN
+BN
1.99 0.17
1.85 0.16
0.56 0.18°
1.35 0.24°''
1.60 0.16°
1.94 0,28"
1.74 0.16
2.33 0.37"
RPF mi/mm —BN
+BN
5.85 0.44
5.20 0.47
1.39 0,38a
3.38 0.41°"'
3.64 0.57°
5.66 1.08"
4.37 0.27°
5.93 1.18"
RBF mi/mm —BN
+BN
10.8 1.30
9.4 0.90
2.77 0.66a
7.03 0.98°''
7.29 0.85k'
11.71 247"
8.40 0.51°
12.06 2.45"
RVR mm Hg. minim! —BN 11.9 1.4
12.7 1.5
48.4 11.8°
18.4 2.9°"
19.8 5.3°
11.8 2.4"
16.9 2.19.4 19b
PCV % —BN
+BN
46 1
49±1
50 ia
51±1
50 ta
51±1
48 1°
50±1
Data are mean SEM. Abbreviations are: MAP, mean arterial pressure; UV, urinary flow; GFR, glomerular filtration rate; RPF, renal plasma
flow; RBF, renal blood flow; RVR, renal vascular resistance; PCV, packed cell volume.
a Statistically significant values (P < 0.05; one-way analysis of variance and multiple mean comparison test) with respect to basal values
b Statistically significant differences (P < 0.05; two-way analysis of variance and multiple means comparison test) with respect to rats without
BN-52021 (BN) treatment
standard curve of response to PAF was made with concentra-
tions between 0.02 nglml and 2 ngiml. The amount of [3H]-
serotonin released for the lower standard was significantly
higher than the non-specific release. The amount of PAF
activity was quantified by interpolating the values of [3HJ-
serotonin release from platelets in presence of 100 d of the
sample in triplicate. Only the values corresponding to the linear
portion of the curve (between 0.02 and 0.4 ng/ml) were used for
quantitation.
Incorporation of[3H]acetate into PAF
Production of PAF by isolated glomeruli or glomerular
mesangial cells was measured by incorporation of [3Hlacetate
into PAF by a modification of the method of Mueller, O'Fla-
herty and Wykle [221. Briefly, freshly isolated glomeruli were
placed in tubes containing 1 ml of Krebs-Henseleit buffer
containing PMSF (10—a M, final concentration), 5 m glucose
and 75 pCi of carrier-free [3H]acetate. After 15 minutes, endo-
thelin or the other agonists and antagonists were added, and
incubated at 37°C for 30 minutes. Incubation was stopped by
addition of 5 ml of HC1 1 N in methanol. Lipids were extracted
from the methanol phase as previously reported, and samples
dried under N2, dissolved in 250 p1 of chloroform/methanol
(9: 1) and separated by thin layer chromatography on precoated
plates of silica gel 60 in propionic/propanol/chloroform/water
(2:2:1:1; vol:vol). The silica was scrapped in fractions corre-
sponding to authentic standards and the [3H1 radioactivity was
determined by liquid scintillation spectrometry.
For studies with mesangial cells, culture bottles containing
400 to 600 g cell protein were washed twice with buffer and
then incubated with 6 ml of the Krebs-Henseleit buffer contain-
ing PMSF (10—a M, final concentration) and 75 pCi of carrier
free [3H]acetate. Endothelin iO' M or control buffer were
added during 30 minutes at 37°C. Then the reaction was stopped
with acidified methanol and cells scraped from the bottles. The
PAF extraction was similar to the method just explained for
glomeruli.
Studies with or without endothelin were always carried out in
paired experiments using the same glomerular suspension or
cell culture bottles of the same culture bath. The results of
[3Fljacetate incorporation are expressed as percentage of
[3H]acetate incorporated by the glomeruli or mesangial cells in
the same experiment in basal conditions ([3H]acetate incorpo-
ration in basal conditions was taken as 100%).
Selected samples from glomeruli or mesangial cell incuba-
tion, after being scraped from the silica gel plate, were sub-
jected to HPLC as previously described [9], and the retention
times of the radioactivity compared with those of PAF stan-
dards.
Statistical methods
Changes with respect to basal values when only two obser-
vations were performed were analyzed by paired or unpaired
Student's t-test. Comparisons between means of multiple
groups were analyzed by one way analysis of variance and
Scheffé's multiple comparisons test. Time course studies were
analyzed by two way analysis of variance.
Results
Endothelin 1 nmol/kg body wt induced a marked decrease of
GFR and RBF and an increase of renal vascular resistance
(RVR) (Table 1). In the third clearance period, these parameteEs
returned to basal values. In rats pretreated with the PAF
antagonist, BN-52021, the changes observed on the first clear-
ance period were lower than in untreated animals. In this group,
the parameters returned to basal values in the second clearance
period. No significant changes in MAP were observed in both
groups (Table 1). Endothelin also induced an increase in packed
cell volume (PCV). In BN-treated rats, we observed a non-
significant increase in PCV. The infusion of BN-52021 alone did
not induce any significant change in renal function or mean
arterial pressure.
Table 2 shows the effects of endothelin on isolated rat
glomeruli. The GCSA at time 0 did not differ among the
experimental groups. However, after 30 minutes of incubation
GCSA of endothelin-treated glomeruli decreased significantly
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Basal 30 mm N P
Saline Saline
1.46 0.03 (72) 1.47 0.03 (73) 5 NS
Saline Endothelin
1.51 0.02 (298) 1.32 0.01 (377) 6 <0.01
BN-52021 BN-52021 + endothelin
1.44 0.02 (134) 1.43 0.01 (235) 5 NS
WEB WEB + endothelin
1.49 0.02 (93) 1.47 0.02 (98) 5 NS
Saline PAF
1.50 0.01 (94) 1.32 0.03 (104) 5 <0.01
BN-52021 BN-52021 + PAF
1.48 0.02 (88) 1.47 0.01 (87) 6 NS
WEB WEB + PAF
1.48 0.02 (83) 1.45 0.02% (93) 6 NS
BN-52021 BN-52021 + angiotensin II
1.46 0.01 (78) 1.30 0.01 (88) 5 <0.01
WEB WEB + angiotensin II
1.50 0.02(63) 1.31 0.02 (70) 5 <0.01
Basal 30 mm N P
Saline Saline
100% (24) 95 3% (24) 5 NS
Saline Endothelin
100% (30) 70.1 7% (30) 6 <0.01
BN-52021 BN-52021 + endothelin
100% (28) 94.0 10% (28) 5 NS
WEB WEB + endothelin
100% (30) 97.1 8% (30) 5 NS
Saline PAF
100% (32) 72 5% (32) 6 <0.01
BN-52021 BN-52021 + PAF
100% (54) 98 2% (54) 6 NS
WEB WEB + PAF
100% (44) 94.2 5 (44) 5 NS
Saline Angiotensin II
100% (88) 75.3 8 (88) 4 <0.01
BN-52021 BN-52021 + angiotensin II
100% (53) 73 6 (53) 5 <0.01
WEB WEB + angiotensin 11
100% (43) 74.4 5 (43) 6 <0.01
with respect to basal values. No changes were detected in
control glomeruli. Preincubation with BN-52021 5. i0 M or
WEB-2170 5.10—i M almost completely inhibited the reduction
of GCSA induced by endothelin iO M. Furthermore, PAF
10—6 M produced a significant reduction on GCSA similar to the
one observed for endothelin, and was blocked by BN-52021 or
WEB-2 170. PAF antagonists were unable to inhibit the reduc-
tion on GCSA induced with angiotensin II iO M.
Data on mesangial cell contraction are shown in Table 3.
Endothelin lO M induced a reduction of planar surface area of
mesangial cells. Preincubation with BN-52021 5.10 M or
WEB-2170 5.10 M completely blunted the contractile re-
0
Supernatant Glomeruli Total
Fig. 1. PAFproduction by isolated glomeruli 2 minutes after endothe-
un io- M, angiotensin II or isotonic saline were added. Asterisks
represent significant differences (P < 0.05) with respect to control
glomeruli. Stars represent significant differences (P < 0.05) with respect
to angiotensin Il-treated glomeruli. Symbols are: •) control; ()
endothelin l0— M; (0) angiotensin II l0 M.
sponse to endothelin i0 M or PAF l0 M. In contrast, when
angiotensin II iO M was added to mesangial cells preincu-
bated for 10 minutes with BN-52021 or WEB-2 170, a significant
reduction of PCSA was observed after 30 minutes of incuba-
tion, which was similar to that observed when mesangial cells
were incubated with angiotensin II alone. BN-52021 or WEB-
2170 did not modify GCSA or PCSA when used alone.
Figures 1 and 2 show the effect of endothelin or angiotensin II
on PAF production by isolated glomeruli. Glomeruli incubated
with endothelin or angiotensin II produced much more PAF
than those incubated in control conditions. This increased
amount of PAF was already observed after two minutes of
incubation with ET or angiotensin II (Fig. 1). However, this
increased PAF was observed predominantly in the glomeruli in
the presence of angiotensin II. On the other hand, ET increased
PAF levels in the incubation buffer. After 30 minutes (Fig. 2),
glomeruli incubated with ET produced more PAF than those
incubated in control conditions or with angiotensin II. In
addition, the increase observed between 2 and 30 minutes of
incubation was higher in endothelin than in angiotensin II
stimulated glomeruli (ET: 68 8, angiotensin II: 20 6 pg
PAF/mg protein).
In the samples obtained after incubation of glomeruli or
mesangial cells with [3H]acetate, more than 90% of the radio-
activity present in the fraction scraped from the silica plates
were recovered in the same HPLC eluates as authentic PAF
standards. 3H]acetate incorporation into PAF was increased in
a dose-response manner in glomeruli incubated with endothelin
with respect to paired glomeruli incubated in the same condi-
tions without endothelin (Table 4). This stimulated {3Hlacetate
Table 2. Effect of endothelin, PAF or angiotensin II and PAF
antagonists on glomerular cross-sectional area
140
120
100
80
60
40
20
C
I',
0
a
0)
E
U-
cc-
0)a
Glomerular cross sectional area is expressed in mm2 10—8 (mean
saM). Data in parentheses are the number of glomeruli measured; N is
the number of experiments performed.
Table 3. Effect of endothelin, PAF or angiotensin II and PAF
antagonists on planar cell surface area
Planar cell surface area is expressed in % with respect to basal (mean
SaM). Data in parentheses are the number of cells measured and N is
the number of experiments performed.
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Supernatart Glomeruli
Fig. 2. PAF production by isolated glomeruli 30 minutes after endo-
thelin iO' si, angiotensin II or isotonic saline were added. Asterisks
represent significant differences (P < 0.05) with respect to control
glomeruli. Stars represent significant differences (P < 0.05) with respect
to angiotensin IT-treated glomeruli. Symbols are: (U) control; ()
endothelin iO M; (El) angiotensin II lO M.
Treatment % E3Hiacetate_incorporation
Control 100
Endothelin 10 M 114.20 20.6
Endothelin iO M 181.10 l4.7
Endothelin iO M 264.27 27
Data are means SEM. Results were represented as % with respect
to the control group (control group was taken as 100% [3H]acetate
incorporation).
a Statistically significant values (P < 0.05; one-way analysis of
variance and multiple mean comparison test) with respect to control
values
incorporation to PAF was already observed after two minutes
of incubation with endothelin i0 M (136.3 + 25.4% over
control, P < 0.05, N = 7). Calcium ionophore A-23 187 (10 M)
also induced an increase in [3H]acetate incorporation into PAF
(Table 5). The pretreatment with verapamil (l0 M) or a
medium without calcium and containing EGTA (2.5 mM) inhib-
ited the endothelin induced increase of [3Hjacetate incorpora-
tion into PAF (Table 5).
On the other hand, [3Hlacetate incorporation into PAF was
also increased in mesangial cells incubated with endothelin iO
M (253.3 41.8) or calcium ionophore A-23 187 10 M (161.5
44.5) with respect to paired cells incubated without endothelin
(this group was taken as 100% [3H]acetate incorporation).
Discussion
The present study demonstrate a functional relation between
the effect of endothelin on renal function and glomerular and
Treatment % [3H]acetate incorporation
Endothelin iO M 264.27 27,7a
Jo A-23187 10—6 M 140.70 22.8
Endothelin + YPA l0— M 164.50 29.3'
Endothelin + EGTA 2.5 mr'i 152.64 l0.6"
Data are means SEM. Results are represented as % with respect to
control group (control group was taken as 100% [3Hjacetate incorpora-
tion). Abbreviations are: lo A-23187, calcium ionophore; VPA, vera-
pamil.
a Statistically significant values (P < 0.05; one-way analysis of
variance and multiple mean comparison test) with respect to control
valuesb Statistically significant values (P < 0.05; one-way analysis of
variances and multiple mean comparison test) with respect to glomeruli
treated with endothelin alone.
mesangial cell contraction and the release and action of PAF in
the kidney. Thus, endothelin, at a dose with a non-significant
pressor effect, is able to induce a marked decrease in glomerular
filtration rate and renal blood flow. Our data also demonstrate a
marked effect of endothelin in reducing planar cell surface area
of cultured mesangial cells, which is considered to be repre-
sentative of mesangial contraction [23]. In agreement with this
effect, endothelin induced a marked reduction of GCSA which
most probably represents contraction of isolated glomeruli.
BN-5202 I or WEB-2 170, two potent specific inhibitors of PAF
receptor [24, 251, blocked the effects of endothelin on renal
function and isolated glomeruli and mesangial cell contraction.
The pretreatment of the glomeruli and the mesangial cells with
the PAF antagonists could prevent the contraction induced by
either synthetic PAF or endothelin, but not by angiotensin II.
Thus, the inhibition by BN-52021 or WEB-2l70 on PAF or
endothelin-induced contraction on glomeruli and mesangial
cells seem to be specific. These data strongly suggest that the
renal actions of endothelin are mediated by the binding of
PAF-acether to its receptors. It must be taken into account that
endothelin and PAF share some physiological properties. First,
both substances induce potent decreases in GFR and RPF when
infused into the kidney or in the systemic circulation [4—61.
Second, both substances are released during ischemia and/or
hypoxia [1, 9]. Third, both substances induce potent contrac-
tion of smooth muscle [1, 26]. Fourth, both substances induce
increases in cytosolic free calcium in mesangial cells [11, 14]. It
has been already demonstrated that renal glomeruli can synthe-
size PAF in response to a number of stimuli [2, 9]. Moreover,
Schlondorif et al [271 demonstrated that platelet activating
factor can be produced by glomerular mesangial cells. Thus to
explore the possibility that PAF-release could mediate the
observed effects of endothelin on cultured mesangial cells and
isolated glomeruli we measured the PAF synthesis by isolated
rat glomeruli in presence of endothelin. To improve the method
of detection, PMSF was added to the incubation media in order
to inhibit the cellular acetyl-hydrolase activity [19]. Moreover,
we performed a previous extraction of the samples to com-
pletely separate PAF from thromboxane B2, and the product
extracted from the column eluted after HPLC chromatography
in a single pike coinciding with that of synthetic PAF [9]. In
200 Table 5. Effect of verapainil or a medium without calcium on[3H]acetate incorporation in isolated glomeruli treated with
endothelin l0 M
C
0
0.
0)
E
U-
a-
0)
a.
150
100
50
0
Table 4. [3H]acetate incorporation at different doses of endothelin in
isolated glomeruli
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these conditions we observed a significant increase in the
production of PAF by isolated glomeruli after incubation with
endothelin. In order to evaluate if any other vasoconstrictor
agent induced similar glomeruli PAF production than observed
with endothelin, we measured the glomeruli PAF production
stimulated by angiotensin II. Angiotensin II induced an increase
in glomerular PAF production. However, Angiotensin 11-in-
duced PAF was detected predominantly in the glomeruli frac-
tion, whereas, in endothelin stimulated glomeruli, PAF was
detected mainly in the incubation buffer. These data suggest
angiotensin II stimulates synthesis but not release of PAF,
whereas endothelin stimulates both synthesis and release of
PAF from glomeruli; this may be a reason to explain why PAF
antagonists inhibited the mesangial cell contraction induced by
endothelin and not the contraction induced by angiotensin II.
The mechanisms explaining the different effects of angiotensin
II and endothelin on PAF release by mesangial cells are outside
the scope of the present study.
PAF synthesis requires specific enzymatic activities. Al-
though more than one pathway for PAF synthesis exists in
mammalian cells, in glomeruli and cultured mesangial cells PAF
synthesis has been reported to occur by the sequential phos-
pholipase A2-catalyzed hydrolysis of l-alkyl-2-acyl-GPC to
form 1 -alkyl-GPC ("lyso-PAF"), followed by acetylation of this
molecule to form PAF (l-alkyl-2-acetyl-GPC), the latter reac-
tion being catalyzed by an intracellular acetyl transferase [281.
The activation of phospholipase A2 depends on increase of
intracellular calcium concentration [28]. Therefore, we have
assessed the activation of this pathway by providing the gb-
meruli and mesangial cells with [3Hjacetate, substrate for
lyso-PAF : acetyl-CoA acetyltransferase [221. We found that
endothelin stimulated in a dose-response manner the incorpo-
ration of [3H]acetate into PAF, in glomeruli. In mesangial cells
a similar [3HIPAF production to glomeruli was observed,
suggesting activation of this pathway. This stimulation can be
also induced by calcium ionophore A-23l87, thus suggesting
that activation of acetyl transferase may be a common response
to agents that induce an intracellular free calcium transient, as
A-23 187 and endothelin. The blockade of such effects by
verapamil or a calcium-free, EGTA containing medium is
further suggestive of a significant role of transmembrane cal-
cium flux through calcium channels in the activation of [3HIac-
etate incorporation into PAF induced by endothelin. We have
reported previously that endothelin action on renal function is
inhibited by the calcium channel blocker verapamil [29]. Fur-
thermore, it has been shown recently that the elevation of
intracellular calcium induced by endothelin on VSMC was
inhibited by nicardipine in a Ca2-containing medium [30].
Taken together, the above reported results suggest that PAF
synthesis and release by the glomerular structures is involved in
the contractile response of rat glomeruli to endothelin. As a
further support of this hypothesis, it has been reported that, in
vascular smooth muscle cells, structurally similar to mesangial
cells, endothelin-induced increase in cytosolic free calcium can
be completely blocked by PAF antagonists [311. In this regard,
we have recently demonstrated that the contractile effects of
cyclosporine A on isolated rat glomeruli and cultured mesangial
cells were mediated by the release of PAF, and were completely
blocked by treatment with PAF-acether antagonists [321, a fact
similar to that reported in the present study.
In conclusion, the present study suggests that the effects of
endothelin on renal function and glomerular and mesangial cells
may be mediated, at least in part, by an increase of PAF
synthesis and release. The physiopathological importance of
the present results needs further studies to be elucidated.
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